We are live on
!
Find out more
SELLAS Life Sciences
18 hedge funds and large institutions have $1.6M invested in SELLAS Life Sciences in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
15% more capital invested
Capital invested by funds: $1.39M → $1.6M (+$204K)
6% more funds holding
Funds holding: 17 → 18 (+1)
0.91% less ownership
Funds ownership: 1.02% → 0.12% (-0.91%)
Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
2
Closed
6
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$1K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.11M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$154K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$17.8K |
| 4 |
Jane Street
New York
|
+$12.3K |
| 5 |
MML Investors Services
Springfield,
Massachusetts
|
+$9.73K |
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$442K |
| 2 |
Renaissance Technologies
New York
|
-$426K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$82K |
| 4 |
6CM
683 Capital Management
New York
|
-$47.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$28K |
